Draft guideline for scoring and reporting interstitial fibrosis Working Group on Fibrosis Banff 09 Colvin RB Banff 2009.

Slides:



Advertisements
Similar presentations
Significance of the total i-score
Advertisements

Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody-mediated rejection D. Dobi,
The Value of Zero-Hour Implantation Biopsies Volker Nickeleit Nephropathology Laboratory, Department of Pathology The University of North Carolina, Chapel.
Preimplantation analysis of kidney biopsies from expanded criteria donors Amaia Sagasta, Ana Sánchez-Escuredo, Frederic Oppenheimer, Manel Solé Department.
Are Network Results Regarding Ocular Coherence Tomography (OCT) Relevant to Clinical Practice and Clinical Trials? Sponsored by the National Eye Institute,
Introduction: Eighth Banff Conference on Allograft Pathology - Edmonton, AB Kim Solez, M.D. and Lorraine C. Racusen.
C4d staining and morphology in protocol biopsies Michael Mengel* For the ESPRIT-Group European Study Group For Protocol Biopsies In Renal Transplantation.
Comparative Biosciences, Inc. 786 Lucerne Drive Sunnyvale, CA Telephone: A TRANSLATIONAL APPROACH TO PRECLINICAL RESEARCH.
Measuring diagnostic accuracy of using digital slides in routine histopathology and analyzing sources of diagnostic errors László FÓNYAD 1st. Dept. of.
Slide 1PUBLICATIONS Racusen/Solez meeting report for AJT. Racusen/Solez meeting report for AJT. Manuscript on antibody-mediated rejection. Manuscript on.
Standardization in Renal Allograft Biopsy Interpretation: The Banff Classification Kim Solez, M.D.
Sum Scores & Components’ Scores Chronic Scores Acute Rejection Scores Lillian W. Gaber University of Tennessee.
Calcineurin Inhibitor Toxicity In Kidney Allograft Protocol Biopsies Neeraja Kambham M.D. Stanford University.
Journal Reading Present by Dr. 陳志榮. The Banff 97 Working Classification of Renal Allograft Pathology Racusen LC, Solez K, Colvin RB, Bonsib.
The Banff Classification: Slide Seminar Kim Solez, M.D.
Donor Organ Selection Criteria: What is Ideal? A Consensus (?) Discussion.
Grading Systems for CTA Rejection Proposals and Prospects David E. Kleiner, M.D., Ph.D. National Cancer Institute.
Summaries by Session Chairs of Banff 2003: C4d scoring/Ab mediated reject. - Bob Colvin GeneAnalysis/Microarrays/Tubulitis/Tolerance - Lorraine Racusen.
HISTOPATHOLOGY OF PANCREAS TRANSPLANTATION
Sum Scores and Scores of Individual Components in Clinical Practice and Clinical Trials Lillian W. Gaber University of Tennessee.
C4d - staining: Comparison of methods C. Seemayer, A. Gaspert, M. Mihatsch.
Diagnostic Assays to Plan Specific Drug Treatment Elizabeth Hammond MD.
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
Pathology of Kidney and the Urinary tract
Reproducibility for C4d immunohistochemistry in renal allografts – results from the Banff Trial Banff Initiative for Quality Assurance in Transplantation.
1 Benign Nephrosclerosis Definition: renal changes in benign hypertension It is always associated with hyaline arteriolosclerosis. mild benign nephrosclerosis.
Polyomavirus nephropathy: updated Helmut Hopfer, Basel, Switzerland.
Sulen Sarioglu, Mehtat Unlu, Mustafa Sakar, Taner Camsari, Mehmet Turkmen, Hulya Ellidokuz Departments of Pathology, Biomedical Technology, Nephrology,
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
An International Ki67 Reproducibility Study Nielsen TO et al. Proc SABCS 2012;Abstract S4-6.
Pathomorphological changes in the tubulointerstitial compartment in primary glomerulopathies S. Kostadinova – Kunovska 1, G. Petrushevska 1, R. Jovanovic.
UK National Renal Transplant EQA Scheme Ian Roberts Department of Cellular Pathology, Oxford Radcliffe Hospitals The National Renal Transplant EQA Scheme.
Table 1. Clinicopathological findings at biopsy Clinical Number of patients Age (years) Gender (%Male) eGFR (ml/min/1.73m 2 ) UPE (g/day) Serum albumin.
Laboratory Handling of the Renal Biopsy Dr. Issam Francis Kuwait 4 th SSN Annual International Conference, Riyadh, April 2009.
D. Serón Nephrology Department Hospital Vall d’Hebron Barcelona Interpretation of sequential protocol biopsies in terms of prognosis and clinical implications.
Pathology of Renal Transplantation
Automated airway evaluation system for multi-slice computed tomography using airway lumen diameter, airway wall thickness and broncho-arterial ratio B.
Figure 5. Targeted inhibition of DNMT enzymes reduces the fibrotic markers collagen and ASMA. The impact of reducing DNMT levels on the expression of fibrosis-related.
From: Postoperative Use of Bevacizumab as an Antifibrotic Agent in Glaucoma Filtration Surgery in the Rabbit Invest. Ophthalmol. Vis. Sci ;50(7):
Severity of primary MPGN, rather than MPGN type, determines renal survival and post- transplantation recurrence risk  M.A. Little, P. Dupont, E. Campbell,
Lymphatic vessels develop during tubulointerstitial fibrosis
Tubuloiterstitial diseases
T. N. Nikonenko, A. V. Trailin and A. S. Nikonenko
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 57, Issue 4, Pages (April 2000)
Volume 67, Issue 1, Pages (January 2005)
Chronic rejection of mouse kidney allografts
What is the best way to measure renal fibrosis
Volume 60, Issue 3, Pages (September 2001)
Exploring longitudinal associations of histologically assessed inflammation with symptoms and radiographic damage in knee osteoarthritis: combined results.
Volume 78, Issue 11, Pages (December 2010)
Volume 65, Issue 6, Pages (June 2004)
The clinical spectrum of tubulointerstitial nephritis
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 67, Issue 1, Pages (January 2005)
Uromodulin storage disease
Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.
Volume 59, Issue 3, Pages (March 2001)
Pathologic features of interstitial nephritis associated with inflammatory bowel disease. Pathologic features of interstitial nephritis associated with.
Erratum: SLE: translating lessons from model systems to human disease
Volume 82, Issue 11, Pages (December 2012)
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
Volume 58, Issue 4, Pages (October 2000)
Kirk J. Maurer, Robert P. Marini, James G. Fox, Arlin B. Rogers 
Volume 72, Issue 6, Pages (September 2007)
Volume 73, Issue 5, Pages (March 2008)
Volume 65, Issue 6, Pages (June 2004)
Steven Ledbetter, Leslie Kurtzberg, Sineaid Doyle, Bruce M. Pratt 
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Severity of primary MPGN, rather than MPGN type, determines renal survival and post- transplantation recurrence risk  M.A. Little, P. Dupont, E. Campbell,
Presentation transcript:

Draft guideline for scoring and reporting interstitial fibrosis Working Group on Fibrosis Banff 09 Colvin RB Banff 2009

Rationale Interstitial fibrosis correlates with function and prognosis in many studies of native and transplant kidneys Reproducibility of pathology assessment of fibrosis is modest at best Definitions and methodology are variable Fibrosis is an endpoint in some clinical trials and a potential surrogate marker of efficacy Colvin RB Banff 2009

Purpose Promote more uniform reporting of interstitial fibrosis, quantitation and reproducibility for routine use and clinical trials Colvin RB Banff 2009

Method Survey pathologists and nephrologists on current practice Develop guidelines based on these practices and discussion Validate recommendations Colvin RB Banff 2009

Banff Fibrosis Survey Results 7/22/09-8/11/09 Nephnppt/RPS/WGN Colvin RB Banff 2009

Mostly pathologists 201 Completed survey 96% of those completed form were pathologists Colvin RB Banff 2009

Trichrome most common (97% Masson) Other stains often used in conjunction with trichrome Colvin RB Banff 2009

Important heterogeneity in definition Those using % area more commonly had morphometry access (59% vs 41%) Colvin RB Banff 2009

Grade I (mild)Mild interstitial fibrosis and tubular atrophy (<25% of cortical area) Grade II (moderate)Moderate interstitial fibrosis and tubular atrophy (26-50% of cortical area) Grade III (severe)Severe interstitial fibrosis and tubular atrophy/loss (>50% of cortical area) Banff definition of fibrosis scores (ci) Is mild but diffuse (>50%) fibrosis ci3?

Most score at low power, overall appearance (69%) Colvin RB Banff 2009

Usual exclusions: normal perivascular tissue, subcapsular cortex Colvin RB Banff 2009

Marked heterogeneity in what should be included Colvin RB Banff 2009

Varied consideration of TA in assessment of fibrosis Colvin RB Banff 2009

Confusion on the definition of ci 1 <50% got the correct answer (6-25) Colvin RB Banff 2009

Majority report % fibrosis (65%) Many report ci score (42%) Colvin RB Banff 2009

Pattern but not activity commonly reported Colvin RB Banff 2009

Cellularity most common measure of activity Colvin RB Banff 2009

Visual Trichrome most common for routine use (76%) Colvin RB Banff 2009

Morphometry is a research (64%) not a clinical tool (3%) Colvin RB Banff 2009

DRAFT RECOMMENDATIONS FOR SCORING AND REPORTING FIBROSIS Fibrosis is defined as abnormal accumulation of fibrillar collagen and associated matrix proteins in the cortical interstitium Colvin RB Banff 2009

ROUTINE PRACTICE Scoring Stain: Trichrome (Masson) (+PAS/H&E/silver) Thickness: 2-4 microns Assessment: Global low power (4-10x), Alternate: Average 20x fields Definition of area: % of cortex affected by fibrosis, Alternate: % area of cortical fibrous tissue by morphometry Include: Cortical interstitium of cortex bounded by glomeruli Areas of tubular loss with minimal fibrosis Periglomerular fibrosis Exclude: Subcapsular cortex Normal fibrous tissue around arteries Areas with inflammation without fibrosis Colvin RB Banff 2009

Reporting Extent:% fibrosis to nearest 5% (or 10%) + Banff ci Pattern:Focal, multifocal, diffuse other terms (to be defined): Loose, dense, striped, periglomerular, subcapsular… Activity:Presence of mononuclear infiltrate in fibrotic areas Evolution:Note comparison with last prior biopsy Normal cortex:% of cortex without fibrosis or tubular atrophy Colvin RB Banff 2009

Guide for scoring interstitial fibrosis in renal biopsies C. Bellamy, Edinburgh

VALIDATION Recommended visual scoring method will be validated by an open multicenter trial ~30 biopsies evaluated in scanned whole slides. Participation open (Banff, RPS, WGN pathologists). Will include transplant and native kidney biopsies. Colvin RB Banff 2009

VALIDATION Virtual slides (Trichrome and PAS) hosted on a web site in Edmonton Two phases: a training set and a validation set of 10 and 30 cases, respectively Scores will be entered via the ”Surveymonkey” system used for the fibrosis survey Other centers are encouraged to provide a few cases each (either as Aperio scans or by sending slides to Michael Mengel to be scanned in Edmonton) Cases will be presented with a trichrome and a PAS, at least 7 glomeruli (two cores preferred but not necessary. Native or transplant biopsy, with a wide range of fibrosis (0-100%).

2-4 micron sections most common (90%) Colvin RB Banff 2009

?Sum of ci and ct ?Average ci and ct ?Higher of ci or ct Confusion on what IF/TA score means Colvin RB Banff 2009

Highly variable maximum Those using morphometry % area less Colvin RB Banff 2009

% cortical area (~morphometry) % involved cortex Maximum varies by definition of fibrosis area Access to morph facilities59%41% Colvin RB Banff 2009

5% most common as upper limit of normal Colvin RB Banff 2009

Clinical trials -visual and morphometry trichrome rec. Colvin RB Banff 2009

Morphometry available to a minority (47%) Colvin RB Banff 2009

Trichrome is most common (42%) for morphometry Sirius red and collagen III also used Colvin RB Banff 2009

CLINICAL TRIALS Visual score As routine, plus MorphometryAt least one technique: Trichrome Sirius red Collagen III Colvin RB Banff 2009

Range expected: Maximum 100% (less with morph method). <5% = normal Normal cortex: Score % of cortex without fibrosis or tubular atrophy Colvin RB Banff 2009